An Innovative Approach to Automated Carbon Dioxide Angiography During Endovascular Abdominal Aortic Aneurysm Repair
CO2-EVAR
CO2-EVAR - An Innovative Approach to Automated Carbon Dioxide Angiography During Endovascular Abdominal Aortic Aneurysm Repair - (Proof of Concept Study)
1 other identifier
observational
65
1 country
1
Brief Summary
The study aims to perform Endovascular Aortic Repair procedures with CO2-Angiography using a standardized an operative Protocol
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2018
CompletedFirst Submitted
Initial submission to the registry
January 19, 2021
CompletedFirst Posted
Study publicly available on registry
January 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 26, 2022
CompletedJanuary 28, 2022
January 1, 2022
3.1 years
January 19, 2021
January 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Technical Success
Technical success to assess the renal ostia and the hypogastric arteries (defined as 100% accuracy correlated to the iodinated contrast agent angiography or IVUS/FUSION techniques)
30 Days
Secondary Outcomes (5)
Image Quality
30 Days
Endoleak Detection
30 Days
CO2 Quantity
30 Days
Aneurysm Exclusion
30 Days
Adverse Events
30 Days
Interventions
Endovascular Aortic Repair using Carbon Dioxide Angiography
Eligibility Criteria
All patients with AAA, undergoing EVAR
You may qualify if:
- Age \> 18 years
- Male, female
- Patients with indication for AAA
- Informed consent achievement
You may not qualify if:
- Severe COPD (Chronic Obstructive Pulmonary Disease)
- Known atrium- or ventricular septal defect with right-left-shunt
- Severe renal arteries atherosclerosis
- Ruptured AAA
- Current partecipation in other interventional studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of experimental diagnostic and specialty medicine - Vascular Surgery
Bologna, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mauro Gargiulo, Prof
Department of experimental diagnostic and specialty medicine - Vascular Surgery - University of Bologna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 19, 2021
First Posted
January 25, 2021
Study Start
December 12, 2018
Primary Completion
December 31, 2021
Study Completion
January 26, 2022
Last Updated
January 28, 2022
Record last verified: 2022-01